These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 46892)

  • 21. Deuterium-oxide-induced histamine release from basophils of allergic subjects. I. Responsiveness to deuterium oxide requires an activation step.
    Kazimierczak W; Plaut M; Knauer KA; Meier HL; Lichtenstein LM
    Am Rev Respir Dis; 1984 Apr; 129(4):592-6. PubMed ID: 6201094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diisopropylfluorophosphate inhibitable step in antigen-induced histamine release from human leukocytes.
    Pruzansky JJ; Patterson R
    J Immunol; 1975 Mar; 114(3):939-43. PubMed ID: 46264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
    Mendoza GR; Minagawa K; Orner FB; Stiehm ER
    Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family.
    Kuna P; Reddigari SR; Schall TJ; Rucinski D; Sadick M; Kaplan AP
    J Immunol; 1993 Mar; 150(5):1932-43. PubMed ID: 7679699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement- and IgE-mediated release of histamine from basophils in vitro. V. Differential effects of drugs modulating arachidonic acid metabolism.
    Farnam J; Grant JA; Lett-Brown MA; Hunt C; Thueson DO; Giclas PC
    J Immunol; 1985 Jan; 134(1):541-7. PubMed ID: 2578053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells.
    Patella V; Casolaro V; Björck L; Marone G
    J Immunol; 1990 Nov; 145(9):3054-61. PubMed ID: 1698870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of histamine release by formyl methionine-containing peptides.
    Siraganian RP; Hook WA
    J Immunol; 1977 Dec; 119(6):2078-83. PubMed ID: 72118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of basophils in allergic disease.
    Knol EF; Mul FP; Lie WJ; Verhoeven AJ; Roos D
    Eur Respir J Suppl; 1996 Aug; 22():126s-131s. PubMed ID: 8871057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors.
    Lichtenstein LM; Kagey-Sobotka A; White JM; Hamilton RG
    J Immunol; 1992 Jun; 148(12):3929-36. PubMed ID: 1376345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
    Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
    J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hapten-modified basophils: a model of human immediate hypersensitivity that can be elicited by IgG antibody.
    Akiyama K; Pruzansky JJ; Patterson R
    J Immunol; 1984 Dec; 133(6):3286-90. PubMed ID: 6208277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of IgE from receptors on human basophils. I. Enhanced passive sensitization for histamine release.
    Pruzansky JJ; Grammer LC; Patterson R; Roberts M
    J Immunol; 1983 Oct; 131(4):1949-53. PubMed ID: 6194222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
    Lint TF; Behrends CL; Baker PJ; Gewurz H
    J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basophil histamine release induced by a substance from stimulated human platelets.
    Orchard MA; Kagey-Sobotka A; Proud D; Lichtenstein LM
    J Immunol; 1986 Mar; 136(6):2240-4. PubMed ID: 2419428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
    Perez HD; Lipton M; Goldstein IM
    J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse mast cell activation and desensitization for immune aggregate-induced histamine release.
    Fox PC; Basciano LK; Siraganian RP
    J Immunol; 1982 Jul; 129(1):314-9. PubMed ID: 6177754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mechanism of basophil histamine release induced by pepstatin A.
    Marone G; Columbo M; Soppelsa L; Condorelli M
    J Immunol; 1984 Sep; 133(3):1542-6. PubMed ID: 6205086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.
    Brunner T; de Weck AL; Dahinden CA
    J Immunol; 1991 Jul; 147(1):237-42. PubMed ID: 1711077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interaction of human and rodent IgE with the human basophil IgE receptor.
    Conrad DH; Wingard JR; Ishizaka T
    J Immunol; 1983 Jan; 130(1):327-33. PubMed ID: 6183355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement activation requirements for histamine release from human leukocytes: influence of purified C3ahu and C5ahu on histamine release.
    Hartman CT; Glovsky MM
    Int Arch Allergy Appl Immunol; 1981; 66(3):274-81. PubMed ID: 6170591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.